Use of novel proteosome inhibitors as a therapeutic strategy in lymphomas current experience and emerging concepts
Abayomi, E. A.
MetadataShow full item record
Precedent from preclinical experiments coupled with two pivotal phase 2 studies in myeloma has focused attention on a potential role for ubiquitin-proteasome pathway in modulating a number of events that occur commonly in the neoplastic process involving proteins in the regulation of cells cycling, growth and differentiation. This influence is vested in the proteasomes which are large complexes of proteolytic enzymes responsible for degradation of many of these intracellular messengers. Logically interest has centred on molecules having the capacity to influence, by degradation, such molecules and although a number of agents are in development bortezomib is the only one currently in clinical use. Velcade, formerly PS-341, is a novel dipeptide boronic acid capable of reversibly inhibiting the 26S proteasome through a range of activities. The latter are anti-proliferative and proapoptotic with the latter blocking nuclear transcription via NF-κ B in addition to down regulating adhesion and inhibiting angiogenesis. Additional changes are mediated in protein folding within the endoplasmic reticulum and contribute to cell death. These concepts are given focus by considering their introduction into treatment of lymphoreticular malignancy. © 2007.
Please cite this item using this persistent URLhttp://hdl.handle.net/10019.1/14580
Showing items related by title, author, creator and subject.
Lymphoma - The immune system in disarray Theme for the 11th Congress of the South African Lymphoma Study Group meeting Jacobs, P.; Wood, L. (2005)[No abstract available]
Impact of the HIV epidemic and Anti-Retroviral Treatment policy on lymphoma incidence and subtypes seen in the Western Cape of South Africa, 2002-2009: Preliminary findings of the Tygerberg Lymphoma Study Group Abayomi, E. A.; Somers, A.; Grewal, R.; Sissolak, G.; Bassa, F.; Maartens, D.; Jacobs, P.; Stefan, C.; Ayers, L. W. (2011)The Tygerberg Lymphoma Study Group was constituted in 2007 to quantify the impact of HIV on the pattern and burden of lymphoma cases in the Western Cape of South Africa which currently has an HIV prevalence of 15%. South ...
Staples, W. G.; Getaz, E. P. (HMPG, 1977-04)A woman of 69 with Lennert's lymphoma (malignant lymphoma with a high content of epithelioid histiocytes) is described. The case is unique in that hepatosplenomegaly was the presenting feature (for which splenectomy was ...